Retatrutide 20mg Lngivx

RETATRUTIDE 20MG — Advanced Triple-Receptor Peptide

Retatrutide is a next-generation investigational peptide designed to target three key metabolic pathways simultaneously: GLP-1, GIP, and Glucagon receptors. This triple-agonist mechanism has positioned Retatrutide as one of the most advanced compounds currently being researched for metabolic optimization, body composition support, and glucose regulation.

Research suggests Retatrutide may support:

• Appetite regulation and satiety
• Improved insulin sensitivity
• Enhanced glucose metabolism
• Increased metabolic activity and energy expenditure
• Advanced fat-loss support within structured protocols

Its unique multi-receptor activity differentiates it from traditional GLP-1 compounds by combining appetite control with potential metabolic and thermogenic support.

Product Details

• Compound: Retatrutide
• Concentration: 20MG Lyophilized Peptide
• Format: Research vial
• Storage: Refrigerated after reconstitution
• Grade: Research Use Only

Important Notice

This product is intended strictly for laboratory and research purposes only.
Not intended for human consumption, diagnosis, treatment, or prevention of any disease.